Patients (UK only) at least 6 months post stroke, with upper limb deficits, may enroll. Patients will be randomized to one of two groups - a group implanted with a device that allows pairing VNS with rehabilitation and a group that only receives rehabilitation (no implant). Patients have two baseline evaluations, one evaluation after implant but before initiation of treatment, and then six weeks of rehabilitation or rehabilitation + VNS, followed by post acute therapy evaluations at 1, 7, and 30 days after the 6-weeks of treatment. The intent is to assess safety and provide preliminary effectiveness information for VNS for upper limb functional improvement after stroke. Implanted patients may receive longer-term treatment and follow-up after the acute study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
21
The Vivistim System provides vagus nerve stimulation (VNS) with rehabilitation movements.
Rehabilitation without device implant and VNS
U. Glasgow / Western Infirmary
Glasgow, Scotland, United Kingdom
Safety
Assessment of adverse events and serious adverse events.
Time frame: 6-weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.